Bank Of America Corp Arvinas, Inc. Transaction History

Bank Of America Corp

$1.12 Trillion
Q2 2024

A detailed history of Bank Of America Corp transactions in Arvinas, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 142,375 shares of ARVN stock, worth $3.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

142,375

Previous 154,486 7.84%

Holding current value

$3.57 Million

Previous $6.38 Million 40.57%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $296,235 - $489,284	-12,111 Reduced 7.84%	142,375 $3.79 Million
Q1 2024 May 15, 2024	SELL	$36.38 - $52.31 $20,009 - $28,770	-550 Reduced 0.35%	154,486 $6.38 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $630,717 - $1.88 Million	44,448 Added 40.19%	155,036 $6.38 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $419,888 - $607,321	19,323 Added 21.17%	110,588 $2.74 Million
Q1 2023 May 12, 2023	BUY	$26.15 - $37.26 $144,766 - $206,271	5,536 Added 6.46%	91,265 $2.49 Million
Q4 2022 Feb 10, 2023	SELL	$32.47 - $57.24 $2.73 Million - $4.82 Million	-84,148 Reduced 49.53%	85,729 $2.93 Million
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $247,828 - $343,242	-5,919 Reduced 3.37%	169,877 $7.56 Million
Q2 2022 Aug 12, 2022	SELL	$36.01 - $74.24 $68,995 - $142,243	-1,916 Reduced 1.08%	175,796 $7.4 Million
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $3.09 Million - $4.18 Million	-51,230 Reduced 22.38%	177,712 $12 Million
Q4 2021 Feb 08, 2022	BUY	$65.85 - $96.21 $2.22 Million - $3.24 Million	33,642 Added 17.23%	228,942 $18.8 Million
Q3 2021 Nov 15, 2021	BUY	$73.2 - $107.87 $5.04 Million - $7.43 Million	68,890 Added 54.5%	195,300 $16.1 Million
Q2 2021 Sep 13, 2021	BUY	$60.45 - $84.26 $7.64 Million - $10.7 Million	126,410 New	126,410 $9.73 Million

Others Institutions Holding ARVN

# of Institutions

224

Shares Held

68.7M

Call Options Held

166K

Put Options Held

31.3K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.33B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Arvinas, Inc. Transaction History